Hypothesis and TheoryPublished 12 October 2026Influencing the exposome, patient macroenvironment, tumor microenvironment through-line to improve clinical outcomesSamuel F. Yanuck · Neil E. AlexisFrontiers in Oncologydoi 10.3389/fonc.2026.1929067
ReviewPublished 2 October 2026Loss of microbial diversity from human–microbe coevolution: immune, epigenetic, and enteric nervous system mechanisms linking dysbiosis to neuropsychiatric and neurodegenerative diseasesHajar Heidari · Michael Brimacombe · David A. LawrenceFrontiers in Neurosciencedoi 10.3389/fnins.2026.1952549
Original ResearchPublished 1 October 2026Xeno-free production of lentiviral particles: implementing hPL as FBS replacement in cell cultureMariana Soares Guedes · Marnie Cole · Daniela YildizFrontiers in Toxicologydoi 10.3389/ftox.2026.1903400
Hypothesis and TheoryPublished 17 September 2026Emerging mechanisms in dry eye disease: apoptosis-associated tear MicroRNAs and toxicant-related alterations of the glycocalyx and lipid raftsMazyar YazdaniFrontiers in Ophthalmologydoi 10.3389/fopht.2026.1924390
EditorialPublished 14 September 2026Editorial: Impact of inhaled particulates and toxicants on brain health: inflammation mechanisms and behavioral consequencesRacheal O. Asaolu · Jagan Srinivasan · Benjamin C. NephewFrontiers in Behavioral Neurosciencedoi 10.3389/fnbeh.2026.1937586
Systematic ReviewPublished 28 May 2026Environmental epigenetic modifiers in neurodegenerative diseases: a systematic review of epigenomic mechanisms and therapeutic targetsPranay Wal · Sunita Mishra · Debashish Pradhan · Ankita Wal · Debashis Purohit · Lalit Mohan Nainwal · Vivek Dhir · Amin GasmiFrontiers in Epigenetics and Epigenomicsdoi 10.3389/freae.2026.1833533
